At a glance
ClinicalIndex Comparison Record- ✓Age 21–80 years
- ✓Paresis of one side with substantial upper limb motor impairment: UEFMA score 10–40/66 or CMSA Hand stage ≤4
- ✓Normal cognitive ability: MOCA score ≥24
- ✓Ability to elevate paretic limb against gravity to at least 75° shoulder flexion and generate active elbow extension
- ✕Motor or sensory impairment in the non-affected limb
- ✕Any brainstem and/or cerebellar lesion
- ✕Severe concurrent medical problems (cardiorespiratory impairment, uncontrolled hypertension, inflammatory joint disease)
- ✕History of neurologic disorder other than stroke (Parkinson's Disease, ALS, MS, TBI, peripheral neuropathy)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of a Portable Synergy Resistant EMG-driven FES Device for Intuitive Control of Grasp and Release During Functional Arm Activities Following Stroke
In Brief
A clinical study evaluating ReIn-Hand device assisted home-based practice for Stroke and Hand Function. Completed, enrolled 3 participants across 1 site.
Detailed Summary
The goal of the study is to develop an individualized, synergy resistant, portable electromyographic (EMG)-driven functional electrical stimulation (FES) device that allows for Reliable and Intuitive control of hand (ReIn-Hand) opening while using the paretic arm during lifting and reaching. Furthermore, to enable sufficient practice intensity both in the clinic and at home, the investigators propose to develop the ReIn-Hand device with easy-to-use utilities by developing a user-customized forearm/hand orthosis with embedded EMG recording and stimulation electrode. To test the device feasibility, a small clinical trial will be conducted. Information related to the clinical trial will be provided below.
Study Details
Timeline
Interventions
Practice reach-grasp-retrieve-release at home with the aid of ReIn-hand device